论文部分内容阅读
目的研究在小儿支气管肺炎治疗中采取单磷酸阿糖腺苷治疗的临床效果。方法 60例小儿支气管肺炎患儿,采取随机数字表法分为参照组与实验组,各30例。两组均给予综合性基础治疗,参照组在此基础上采用头孢曲松常规抗感染治疗,实验组在参照组基础上采用单磷酸阿糖腺苷治疗,对比两组患儿临床治疗效果及各项症状体征消失时间。结果实验组治疗总有效率为96.67%,明显高于参照组的76.67%,差异具有统计学意义(P<0.05)。经治疗后实验组患儿咳嗽消失时间(6.53±0.23)d、退热时间(1.42±0.21)d、肺部啰音消失时间(4.35±0.54)d,参照组患儿咳嗽消失时间(8.11±0.27)d、退热时间(2.14±0.23)d、肺部啰音消失时间(6.14±0.25)d,实验组各项临床症状及体征消失时间均少于参照组,差异具有统计学意义(P<0.05)。结论将单磷酸阿糖腺苷治疗应用于小儿支气管肺炎中疗效比较显著,可以提升治疗依从性,改善患儿生存质量,值得广泛应用。
Objective To study the clinical effect of taking adenosine monophosphate in the treatment of bronchial pneumonia in children. Methods Sixty children with bronchopneumonia were divided into reference group and experimental group by random number table method, 30 cases in each group. The two groups were given a comprehensive basic treatment, the reference group on this basis with conventional anti-infective ceftriaxone treatment group in the reference group based on the use of monophosphate phosphoglycoside treatment, compared two groups of children with clinical treatment and each Signs and symptoms disappear time. Results The total effective rate of the experimental group was 96.67%, which was significantly higher than 76.67% of the reference group, the difference was statistically significant (P <0.05). After treatment, the disappearance time of cough (6.53 ± 0.23) d, the fever time (1.42 ± 0.21) days, the pulmonary rales disappearance time (4.35 ± 0.54) d and the disappearance time of cough in the reference group (8.11 ± (P <0.27) d, antipyretic time (2.14 ± 0.23) d, pulmonary rales disappeared time (6.14 ± 0.25) d, clinical symptoms and signs disappeared in the experimental group were less than the reference group, the difference was statistically significant (P <0.05). Conclusion The treatment of adenosine monophosphate in children with bronchopneumonia is more effective in treating bronchial pneumonia, which can improve the compliance of treatment and improve the quality of life in children, which deserves wide application.